Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zimran

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
The Israel Journal of Psychiatry and Related Sciences|January 1, 1984
Factitious disorder: reflections on primary and secondary gain in Munchausen syndromeR Z Fisch, A Zimran
Blood Cells, Molecules & Diseases|March 28, 1998
Cytokine mRNA in Gaucher diseaseM Lichtenstein, A Zimran, M Horowitz
The Quarterly Journal of Medicine|April 1, 1989
Quality of life and survival following intensive medical careA Yinnon, A Zimran, C Hershko
Pharmaceutical Research|April 23, 1999
Cerebroside-beta-glucosidase encapsulation in liposomes for Gaucher's disease treatment revisitedV Korablyov, A Zimran, Y Barenholz
Eye (London, England)|October 7, 2006
Uveitis and Fabry diseaseD Elstein, G Altarescu, A Zimran
The Journal of Rheumatology|December 1, 1986
Hyperkalemia associated with sulindac therapyG Nesher, A Zimran, C Hershko
The Israel Medical Association Journal : IMAJ|May 11, 2000
Children with type I Gaucher disease: growing into adulthood with and without enzyme therapyA Zimran, A Abrahamov, D Elstein
Lancet (London, England)|February 18, 1995
Enzyme replacement therapy in type 1 and type 3 Gaucher's diseaseA Zimran, D Elstein, A Abrahamov
British Medical Journal (Clinical Research Ed.)|February 4, 1984
Treatment with captopril for peripheral ischaemia induced by ergotamineA Zimran, B Ofek, C Hershko
Harefuah|December 16, 1984
[Ergot poisoning]A Zimran, B Ofek, C Hershko
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
The Israel Journal of Psychiatry and Related Sciences|January 1, 1984
Factitious disorder: reflections on primary and secondary gain in Munchausen syndromeR Z Fisch, A Zimran
Blood Cells, Molecules & Diseases|March 28, 1998
Cytokine mRNA in Gaucher diseaseM Lichtenstein, A Zimran, M Horowitz
The Quarterly Journal of Medicine|April 1, 1989
Quality of life and survival following intensive medical careA Yinnon, A Zimran, C Hershko
Pharmaceutical Research|April 23, 1999
Cerebroside-beta-glucosidase encapsulation in liposomes for Gaucher's disease treatment revisitedV Korablyov, A Zimran, Y Barenholz
Eye (London, England)|October 7, 2006
Uveitis and Fabry diseaseD Elstein, G Altarescu, A Zimran
The Journal of Rheumatology|December 1, 1986
Hyperkalemia associated with sulindac therapyG Nesher, A Zimran, C Hershko
The Israel Medical Association Journal : IMAJ|May 11, 2000
Children with type I Gaucher disease: growing into adulthood with and without enzyme therapyA Zimran, A Abrahamov, D Elstein
Lancet (London, England)|February 18, 1995
Enzyme replacement therapy in type 1 and type 3 Gaucher's diseaseA Zimran, D Elstein, A Abrahamov
British Medical Journal (Clinical Research Ed.)|February 4, 1984
Treatment with captopril for peripheral ischaemia induced by ergotamineA Zimran, B Ofek, C Hershko
Harefuah|December 16, 1984
[Ergot poisoning]A Zimran, B Ofek, C Hershko
Pageof 14